Get Started
Customer Resources
LivingConnected® Clinical Solution
LivingConnected® Clinical Solution
For Partners
Reorder

Tandem Mobi System

Features
  • Control-IQ + Technology
  • AutoBolus Feature
  • Mobile App Control (device compatibility)
  • Simplified Pairing Process
  • User-Friendly Interface
Integrations
  • Dexcom G6 & G7

Specifications

For further warranty information, instructions on appropriate use, and disclaimers, visit the manufacturer website: tandemdiabetes.com

See More

Description

Important Safety Information

RX ONLY.

Indications for Use

Tandem Mobi system: The Tandem Mobi insulin pump with interoperable technology (the pump) is intended for the subcutaneous delivery of insulin, at set and variable rates, for the management of diabetes mellitus in persons requiring insulin. The pump is able to reliably and securely communicate with compatible, digitally connected devices, including automated insulin dosing software, to receive, execute, and confirm commands from these devices. The pump is intended for single patient, home use and requires a prescription. The pump is indicated for use in individuals 6 years of age and greater.

Control-IQ+ technology: Control-IQ+ technology is intended for use with compatible integrated continuous glucose monitors (iCGM, sold separately) and alternate controller enabled (ACE) pumps to automatically increase, decrease, and suspend delivery of basal insulin based on iCGM readings and predicted glucose values. It can also deliver correction boluses when the glucose value is predicted to exceed a predefined threshold. Control-IQ+ technology is intended for the management of type 1 diabetes mellitus in persons 2 years of age and greater and of type 2 diabetes mellitus in persons 18 years of age and greater.

Warning: Control-IQ+ technology should not be used in anyone under the age of 2 years old with type 1 diabetes or under the age of 18 years old with type 2 diabetes. It should also not be used in patients who require less than a total daily insulin dose of 5 units of insulin per day or who weigh less than 20 pounds (9 kilograms), as those are the required minimum values needed for Control-IQ+ to operate safely.

Users of the pump and Control-IQ+ must: use the insulin pump, iCGM, and all other system components in accordance with their respective instructions for use. Failure to follow these instructions for use could result in an over delivery or under delivery of insulin.  This can cause hypoglycemia (low BG) or hyperglycemia (high BG) events. Visit tandemdiabetes.com/safetyinfo for additional important safety information.

See More
Back to Catalogue

Frequently Asked Questions

Who is responsible for getting the insurance authorizations for medical supplies?

Does the company provide service and supplies to Medicare and Medicaid patients?

Are you a participating provider with other insurance companies?

Are all products covered by my insurance company?

How much will a patient have to pay for his or her product?

Do I need to apply for Medicare when I turn 65?

Who can receive benefits for diabetes self-management training?

How do I know my diabetes supplies are covered by Medicare?

How much is reimbursed for each product?

Does everyone pay the same amount for the Part B premium?

Are there limits on the quantity of diabetes supplies that Medicare will reimburse?

How do I replace my Medicare card?

If I am 65 and ready to retire and my employer is going to provide me with benefits, do I need Medicare?

Does Medicare cover my spouse and family?

What is the difference between Medicare and Medicaid?

Where should I send my Medicare premium payment?

Who can I contact for more information about Medicare eligibility?